• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨桥蛋白肺基因表达是肺动脉高压疾病严重程度的一个标志物。

Osteopontin lung gene expression is a marker of disease severity in pulmonary arterial hypertension.

机构信息

Division of Respirology, Western University, London, ON, Canada.

Toronto Lung Transplant Program, University of Toronto, Toronto, ON, Canada.

出版信息

Respirology. 2019 Nov;24(11):1104-1110. doi: 10.1111/resp.13557. Epub 2019 Apr 8.

DOI:10.1111/resp.13557
PMID:30963672
Abstract

BACKGROUND AND OBJECTIVE

Osteopontin (OPN) is a pleiotropic cytokine involved in the proliferation of pulmonary artery smooth muscle cells (PA-SMC). OPN is upregulated in the lungs of patients with pulmonary hypertension (PH) associated with pulmonary fibrosis, suggesting that the lung is a source of OPN. We hypothesized that OPN lung expression is elevated in Group I pulmonary arterial hypertension (PAH) and is correlated to haemodynamics.

METHODS

Microarray analysis (Affymetrix) was performed after RNA was extracted from explanted lungs in 15 patients with Group I PAH who underwent lung transplantation (LTx) and 11 normal controls. PA pressure levels were recorded intraoperatively, immediately before starting LTx. Serum OPN levels were measured in subjects with PAH, Group II PH and normal controls on the day of right heart catheterization.

RESULTS

OPN was among the top five upregulated genes in PAH compared to normal controls, which was confirmed by reverse transcription polymerase chain reaction (RT-PCR). OPN expression was similar and equally elevated in different subtypes of PAH. A strong significant correlation was observed between mean pulmonary arterial pressure and OPN gene expression. Ingenuity pathway analysis showed the involvement of OPN in functions and networks relevant to angiogenesis, cell death and proliferation of PA-SMC. OPN serum levels did not differ in subjects with Group I PAH and Group II PH.

CONCLUSION

In the lungs of patients with severe PAH, OPN is highly expressed and the level of expression is significantly correlated to disease severity. OPN may play an important role in the vascular remodelling process of PAH.

摘要

背景与目的

骨桥蛋白(OPN)是一种多效细胞因子,参与肺动脉平滑肌细胞(PA-SMC)的增殖。OPN 在与肺纤维化相关的肺动脉高压(PH)患者的肺部上调,这表明肺是 OPN 的来源。我们假设 I 型肺动脉高压(PAH)患者的肺中 OPN 表达升高,并且与血液动力学相关。

方法

从 15 例接受肺移植(LTx)的 I 型 PAH 患者和 11 例正常对照者的肺组织中提取 RNA 后,进行微阵列分析(Affymetrix)。在开始 LTx 之前,术中记录肺动脉压力水平。在右心导管检查当天,测量 PAH 患者、II 型 PH 患者和正常对照者的血清 OPN 水平。

结果

与正常对照者相比,OPN 是 PAH 中上调最多的前五名基因之一,这通过逆转录聚合酶链反应(RT-PCR)得到了证实。PAH 的不同亚型中 OPN 的表达相似且同样升高。平均肺动脉压与 OPN 基因表达之间存在强烈的显著相关性。Ingenuity 通路分析表明 OPN 参与与血管生成、PA-SMC 死亡和增殖相关的功能和网络。I 型 PAH 和 II 型 PH 患者的 OPN 血清水平无差异。

结论

在严重 PAH 患者的肺部,OPN 高表达,表达水平与疾病严重程度显著相关。OPN 可能在 PAH 的血管重塑过程中发挥重要作用。

相似文献

1
Osteopontin lung gene expression is a marker of disease severity in pulmonary arterial hypertension.骨桥蛋白肺基因表达是肺动脉高压疾病严重程度的一个标志物。
Respirology. 2019 Nov;24(11):1104-1110. doi: 10.1111/resp.13557. Epub 2019 Apr 8.
2
PDZ-Binding Kinase, a Novel Regulator of Vascular Remodeling in Pulmonary Arterial Hypertension.PDZ 结合激酶:肺动脉高压血管重构的新型调节因子。
Circulation. 2024 Jul 30;150(5):393-410. doi: 10.1161/CIRCULATIONAHA.123.067095. Epub 2024 Apr 29.
3
[Potential therapeutic target for pulmonary arterial hypertension--osteopontin].[肺动脉高压的潜在治疗靶点——骨桥蛋白]
Nihon Rinsho. 2008 Nov;66(11):2097-101.
4
Osteopontin plays important roles in pulmonary arterial hypertension induced by systemic-to-pulmonary shunt.骨桥蛋白在体肺分流引起的肺动脉高压中发挥重要作用。
FASEB J. 2019 Jun;33(6):7236-7251. doi: 10.1096/fj.201802121RR. Epub 2019 Mar 20.
5
Osteopontin, a Key Mediator Expressed by Senescent Pulmonary Vascular Cells in Pulmonary Hypertension.骨桥蛋白,肺动脉高压中衰老肺血管细胞表达的关键介质。
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1879-90. doi: 10.1161/ATVBAHA.116.307839. Epub 2016 Jul 21.
6
Remodeling Matrix Synthesis in a Rat Model of Aortocaval Fistula and the Cyclic Stretch: Impaction in Pulmonary Arterial Hypertension-Congenital Heart Disease.大鼠腔静脉瘘和周期性拉伸模型中的重塑基质合成与肺动脉高压-先天性心脏病的撞击。
Int J Mol Sci. 2020 Jun 30;21(13):4676. doi: 10.3390/ijms21134676.
7
Influence of long-standing pulmonary arterial hypertension and its severity on pulmonary artery aneurysm development.长期肺动脉高压及其严重程度对肺动脉瘤形成的影响。
Heart Vessels. 2020 Sep;35(9):1290-1298. doi: 10.1007/s00380-020-01600-5. Epub 2020 Apr 4.
8
Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.尼达尼布可改善心脏纤维化,但不能改变实验性肺动脉高压中的肺血管重构。
Cardiovasc Res. 2019 Feb 1;115(2):432-439. doi: 10.1093/cvr/cvy186.
9
RGS5 as a Biomarker of Pericytes, Involvement in Vascular Remodeling and Pulmonary Arterial Hypertension.RGS5 作为周细胞的生物标志物,参与血管重塑和肺动脉高压。
Vasc Health Risk Manag. 2023 Oct 20;19:673-688. doi: 10.2147/VHRM.S429535. eCollection 2023.
10
DAN plays important compensatory roles in systemic-to-pulmonary shunt associated pulmonary arterial hypertension.DAN 在体循环到肺循环分流相关肺动脉高压中发挥重要的代偿作用。
Acta Physiol (Oxf). 2019 Jul;226(3):e13263. doi: 10.1111/apha.13263. Epub 2019 Feb 27.

引用本文的文献

1
Bioinformatics Analysis Identifies a Potential Key Gene in the Pathogenesis of Pulmonary Hypertension-HSPH1.生物信息学分析确定了肺动脉高压发病机制中的一个潜在关键基因——HSPH1。
Pulm Circ. 2025 Jul 16;15(3):e70127. doi: 10.1002/pul2.70127. eCollection 2025 Jul.
2
Hypoxia- and mechanical stress-induced upregulation of mitochondrial HSP60 is associated with phenotypic switching of pulmonary arterial smooth muscle cells.缺氧和机械应激诱导的线粒体热休克蛋白60上调与肺动脉平滑肌细胞的表型转换有关。
Cell Stress Chaperones. 2025 Jul;30(4):100089. doi: 10.1016/j.cstres.2025.100089. Epub 2025 Jul 2.
3
Identification of a PANoptosis-related gene signature reveals therapeutic potential of SFRP2 in pulmonary arterial hypertension.
一种PAN细胞焦亡相关基因特征的鉴定揭示了SFRP2在肺动脉高压中的治疗潜力。
Front Cardiovasc Med. 2025 Apr 29;12:1521087. doi: 10.3389/fcvm.2025.1521087. eCollection 2025.
4
The sonic hedgehog signaling inhibitor cyclopamine improves pulmonary arterial hypertension via regulating the bone morphogenetic protein receptor 2 pathway.音猬因子信号通路抑制剂环杷明通过调节骨形态发生蛋白受体2信号通路改善肺动脉高压。
Sci Rep. 2025 Apr 11;15(1):12512. doi: 10.1038/s41598-025-97627-7.
5
Combined analysis of single-cell and bulk transcriptome sequencing data identifies critical glycolysis genes in idiopathic pulmonary arterial hypertension.单细胞和批量转录组测序数据的联合分析确定了特发性肺动脉高压中的关键糖酵解基因。
J Transl Med. 2025 Mar 26;23(1):373. doi: 10.1186/s12967-025-06373-x.
6
The immune duality of osteopontin and its therapeutic implications for kidney transplantation.骨桥蛋白的免疫双重性及其在肾移植中的治疗意义
Front Immunol. 2025 Feb 28;16:1520777. doi: 10.3389/fimmu.2025.1520777. eCollection 2025.
7
Risk associated circulating biomarkers S100A3 identified in congenital heart disease-associated pulmonary arterial hypertension.先天性心脏病相关肺动脉高压中鉴定出的循环生物标志物S100A3的相关风险。
Intractable Rare Dis Res. 2025 Feb 28;14(1):36-45. doi: 10.5582/irdr.2024.01064.
8
Interplay of Transcriptomic Regulation, Microbiota, and Signaling Pathways in Lung and Gut Inflammation-Induced Tumorigenesis.肺和肠道炎症诱导肿瘤发生过程中转录组调控、微生物群与信号通路的相互作用
Cells. 2024 Dec 24;14(1):1. doi: 10.3390/cells14010001.
9
Serum proteome profiling reveals HGFA as a candidate biomarker for pulmonary arterial hypertension.血清蛋白质组谱分析显示 HGFA 是肺动脉高压的候选生物标志物。
Respir Res. 2024 Nov 28;25(1):418. doi: 10.1186/s12931-024-03036-1.
10
Bioinformatic Analysis and Molecular Docking Identify Isorhamnetin Is a Candidate Compound in the Treatment of Pulmonary Artery Hypertension.生物信息学分析和分子对接表明异鼠李素是治疗肺动脉高压的候选化合物。
Anatol J Cardiol. 2025 Nov 28;29(2):52-65. doi: 10.14744/AnatolJCardiol.2024.4723.